For healthcare professionals only. This meeting is organized and funded by Alnylam® Pharmaceuticals. Please note that some of the meeting sessions will include data specific to products from Alnylam®.
ATTR, transthyretin amyloidosis; hATTR, hereditary transthyretin amyloidosis.
TTR02-CEMEA-00396 September 2020